Miatello R M, Lama M C, González E S, Nolly H L
Laboratory of Experimental Hypertension and Vasoactive Peptides, Argentine Council of Research (CONICET). Mendoza.
Agents Actions Suppl. 1992;38 ( Pt 1):106-13. doi: 10.1007/978-3-0348-7321-5_14.
SBTI-resistant kininogenase activity was found in nonpregnant and pregnant rat uterus, placenta, amniotic fluid and fetal membranes. After trypsin treatment the kininogenase activity increased 2-3 fold. Total kininogenase (active plus inactive) was completely blocked by kallikrein antibodies. The physiological role of these kallikrein-like enzymes is unknown. It is speculated that these enzymes play a local role, perhaps in the processing of polypeptide hormones of through the release of kinins in the regulation of uterine blood flow.
在未孕和孕鼠的子宫、胎盘、羊水和胎膜中发现了抗大豆胰蛋白酶抑制剂(SBTI)的激肽原酶活性。经胰蛋白酶处理后,激肽原酶活性增加了2至3倍。总激肽原酶(活性加非活性)被激肽释放酶抗体完全阻断。这些类激肽释放酶的生理作用尚不清楚。据推测,这些酶可能发挥局部作用,也许是在多肽激素的加工过程中,或者是通过释放激肽来调节子宫血流。